QuickView for IDR-1018 (compound)

1. IDR-1018 treatment of Plasmodium berghei infection; spleen and brain expression data
2. Cystic fibrosis cells with mutant or corrected CFTR treated with flagellin and IDR-1018
3. Monocytes treated with synthetic innate defense regulator-IDR-1018, expression profiling
4. Peripheral blood mononuclear cells from cystic fibrosis patients treated with flagellin and IDR 1018

1. Investigation of the effects of antimicrobial and anti-biofilm peptide IDR1018 and chitosan nanopart…
2. Bioinformatics-based analysis reveals IDR-1018-mediated ceRNA regulation network for protective effe…
3. Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antim…
4. Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflam…
5. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, M…

There were no clinical trials for IDR-1018